Tag Archives: Covid-19

Lab experiments in the pandemic moved online or mailed home to uni students


<figure> <img src=”https://images.theconversation.com/files/338458/original/file-20200529-51449-15pz5hk.jpg?ixlib=rb-1.1.0&rect=29%2C29%2C4542%2C2807&q=45&auto=format&w=754&fit=clip” /> <figcaption> <span class=”attribution”><span class=”source”>hxdbzxy/Shutterstock</span></span> </figcaption> </figure> <span><a href=”https://theconversation.com/profiles/brian-abbey-104998″>Brian Abbey</a>, <em><a href=”https://theconversation.com/institutions/la-trobe-university-842″>La Trobe University</a></em> and <a href=”https://theconversation.com/profiles/david-hoxley-1083894″>David Hoxley</a>, <em><a href=”https://theconversation.com/institutions/la-trobe-university-842″>La Trobe University</a></em></span> <p>The COVID-19 pandemic has shaken university education, with most teaching moved off campus and students learning online at home.</p> <p>But a cornerstone of undergraduate science education has been a challenge: the laboratory class.</p> <p>The real …

Read More »

COVID-19 vaccines: Open source licensing could keep Big Pharma from making huge profits off taxpayer-funded research

How many vaccines will be needed to vaccinate the world against COVID-19? Tetra Images/Getty Images

<figure> <img src=”https://images.theconversation.com/files/357982/original/file-20200914-18-qfqjei.jpg?ixlib=rb-1.1.0&rect=71%2C26%2C5911%2C4126&q=45&auto=format&w=754&fit=clip” /> <figcaption> How many vaccines will be needed to vaccinate the world against COVID-19? <span class=”attribution”><a class=”source” href=”https://www.gettyimages.com/detail/photo/covid-19-vaccine-with-world-map-in-background-royalty-free-image/1248797862?adppopup=true”>Tetra Images/Getty Images</a></span> </figcaption> </figure> <span><a href=”https://theconversation.com/profiles/charles-m-schweik-1107510″>Charles M Schweik</a>, <em><a href=”https://theconversation.com/institutions/university-of-massachusetts-amherst-1563″>University of Massachusetts Amherst</a></em> and <a href=”https://theconversation.com/profiles/timothy-ford-1154482″>Timothy Ford</a>, <em><a href=”https://theconversation.com/institutions/university-of-massachusetts-lowell-1534″>University of Massachusetts Lowell</a></em></span> <p>An international, multi-billion-dollar race is underway to develop a COVID-19 vaccine, and progress is <a href=”https://www.cnn.com/interactive/2020/08/health/coronavirus-vaccine-race-intl/”>moving at …

Read More »

Video: Who should get a COVID-19 vaccine first?

Production limits mean that not everyone can get access to a COVID-19 vaccine as soon as it’s developed.. GIPhotoStock/Cultura via Getty Images Nicole Hassoun, Binghamton University, State University of New York A committee of The National Academies of Sciences, Engineering and Medicine is readying a report with recommendations for equitable distribution of a COVID-19 vaccine. In this Q&A, bioethicist Dr. …

Read More »

¿Por qué es una buena noticia que se suspendan los ensayos de una vacuna?

F8 studio/Shutterstock

F8 studio/Shutterstock Carmen Álvarez Domínguez, UNIR – Universidad Internacional de La Rioja El reciente anuncio de Oxford suspendiendo el ensayo clínico con la vacuna para SARS-CoV-2 debido a un efecto adverso denominado Mellitis transversa, una inflamación de la médula espinal, tras un análisis rutinario de un voluntario vacunado, es una buena noticia por varias razones. Primero, refleja que las agencias …

Read More »

5 ways our immune responses to COVID vaccines are unique


Shutterstock Paul Gill, Monash University y Menno van Zelm, Monash University The Oxford vaccine trial at the centre of safety concerns this week highlights the idea that people’s immune systems respond to vaccines differently. We don’t yet know whether reports of immune complications in one or two trial participants have been linked to the COVID-19 vaccine itself, or if they …

Read More »

La integración latinoamericana ante la encrucijada del coronavirus

Shutterstock / Harvepino

Shutterstock / Harvepino Ángeles Sánchez Díez, Universidad Autónoma de Madrid y Laura Pérez Ortiz, Universidad Autónoma de Madrid La integración regional en América Latina vive un momento decisivo ante los importantes retos del futuro más inmediato. Si ya antes de la pandemia el escenario económico y social latinoamericano no era bueno, ahora ha empeorado. Los organismos internacionales estiman importantes caídas …

Read More »

An infectious disease expert explains the results from Moderna’s latest vaccine trials

An infectious disease expert explains the results from Moderna's latest vaccine trials

Biotech company Moderna, one of many organizations developing a vaccine for COVID-19, published results from an early-stage test of its experimental mRNA vaccine in the New England Journal of Medicine on July 14. Vanderbilt University Medical Center staff scientist and protein chemistry expert Sanjay Mishra explains what the results of the phase 1 trial mean. Licence Creative Commons Attribution licence …

Read More »